Search

Your search keyword '"Briers E"' showing total 103 results

Search Constraints

Start Over You searched for: Author "Briers E" Remove constraint Author: "Briers E"
103 results on '"Briers E"'

Search Results

2. Patient-reported fatigue up to five years after radiotherapy in an international multicentre cohort study of men with non-metastatic prostate cancer

3. Understanding the barriers to prostate cancer population-based early detection programs: The PRAISE-U BEST survey

4. Why is there a need to re-think prostate cancer early detection?

5. A systematic review of the efficacy and toxicity of brachytherapy boost combined with external beam radiotherapy for nonmetastatic prostate cancer

6. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.

7. Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304–6: Prebiopsy MRI: Through the Looking Glass

8. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer

9. Evaluation of oncological outcomes and data quality in studies assessing nerve sparing versus non-nerve sparing radical prostatectomy in non-metastatic prostate cancer: A systematic review

10. A systematic review on the impact of surgeon and hospital caseload volume on oncological and non-oncological outcomes after radical prostatectomy for non-metastatic prostate cancer

11. Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.016: Prebiopsy MRI: Through the Looking Glass

12. 'TREXIT 2020': why the time to abandon transrectal prostate biopsy starts now

13. PT348 - Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: A systematic review

14. The EAU biochemical recurrence risk stratification after radical prostatectomy

15. Current treatment options for locally advanced prostate cancer: EAU (-SIOG) guidelines view and recommendations

16. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

17. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: A systematic review

18. Systematic review of quality of life outcomes after primary treatment for clinically localised prostate cancer

19. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis

20. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: A systematic review

21. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

22. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy?

26. PT008 - What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis

27. PT010 - Systematic review of quality of life outcomes after primary treatment for clinically localised prostate cancer

28. Policy statement on multidisciplinary cancer care

30. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research

31. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

32. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

33. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review

34. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

35. A0666 - Why is there a need to re-think prostate cancer early detection?

36. A0665 - Understanding the barriers to prostate cancer population-based early detection programs: The PRAISE-U BEST survey.

37. Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer

38. A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer

39. Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non–Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review

40. Biochemical Recurrence in Prostate Cancer : The European Association of Urology Prostate Cancer Guidelines Panel Recommendations

41. Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer

42. Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.

43. Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories.

44. Prostate Cancer Early Detection in the European Union and UK.

45. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

46. A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.

47. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

48. Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey.

50. How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?

Catalog

Books, media, physical & digital resources